Pilot Study: Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR)

This proposal will help identify the natural history of eosinophilic gastrointestinal disorders, identify prognostic and non-invasive biomarkers, establish research and treatment algorithms, evaluate new treatments, and support clinical trials and high risk–high return pilot studies. Furthermore, consortiums such as the one proposed can play a pivotal role in the training of physicians and investigators and educating the public and lay organizations about eosinophilic gastrointestinal diseases.